SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
76 hedge funds and large institutions have $246M invested in Syros Pharmaceuticals, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
0% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 25
Holders
76
Holding in Top 10
1
Calls
$464K
Puts
$279K
Top Buyers
| 1 | +$5.03M | |
| 2 | +$1.92M | |
| 3 | +$1.79M | |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$731K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$519K |
Top Sellers
| 1 | -$2.41M | |
| 2 | -$1.63M | |
| 3 | -$1.59M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.01M |
| 5 |
Two Sigma Investments
New York
|
-$715K |